Clinical outcome measures in multiple sclerosis: A review

Hernan Inojosa1, Dirk Schriefer1, Tjalf Ziemssen1

  • 1MS Center, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Fetscherstr. 74, 01307 Dresden, Germany.

Autoimmunity Reviews
|March 17, 2020
PubMed
Summary

Evaluating Multiple Sclerosis (MS) progression requires robust clinical outcome measures (COMs). This review examines current and emerging COMs for MS, focusing on their ability to detect disease changes and treatment response.

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
338